Pharmaceutical CRO in Northern Europe for sale

CRO company in Northern Europe for sale

• Sales: >15M EUR
• Location: Northern Europe
• Employees: 200+
• Reason for sale: The owners are considering an exit, as it could help their company to grow further under a new owner/investor
• #CFIE PHS020

Overview of this CRO in Northern Europe for sale

The owners of this clinical research organization located in Northern Europe are considering a sale to a larger strategic investor. The acquisition is suited for a pharmaceutical company willing to take on CRO research activities under its own roof. Please contact us to get more details about this company.

Profile of this CRO company in Northern Europe

This company for sale is a relatively large clinical research organization (CRO) based in Northern Europe. Specialization of this company is preclinical research, conducted according to client’s specifications. Currently, the company is privately-held and has been founded approximately 15 years ago.

Currently, more than 200 employees are working for this company, most of them highly skilled pharma, medical or biotech professionals, which are very hard to find on the market.

The company is working with top brands from the pharma and biotech industry. The owners are proud of the high-quality services and good reputation held by the company.

The company has a proven client satisfaction, with a number of positive references from top pharma companies. The buyer would gain an interestingly scaled CRO, and good access to pharma clients from the globe.

The company has a proven customer satisfaction, with a number of positive references from top pharma companies. The new owners can enter the company via a share acquisition or a capital increase.

Products and services of this pharma clinical research organization in Northern Europe

This company for sale is mainly focusing on its core activities, which is

• pre-clinical contract research services
• drug discovery services

The company has a global reach, currently working with companies from 20+ companies from all over the world, from 4 continents.

The specialization of the company is in the following:

• molecular pharma
• vivo pharma
• peptides
• stereology
• imaging

The company has a stable revenue of more than 15M, with an EBITDA reaching 1M EUR. The company is not in a large debt.

Highlights of the CRO company in Northern Europe

• The company is working with top brands from the pharma and biotech industry.
• The company has a global reach, currently working with companies from 20+ companies from all over the world
• Specialization of this company is preclinical research, conducted according to client’s specifications.

More information on this pharmaceutical CRO in Northern Europe for sale

Please get in touch if you are interested in learning more about this pharmaceutical CRO in Northern Europe for sale. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.